Details for New Drug Application (NDA): 020551
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in NIMBEX PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 020551
Tradename: | NIMBEX PRESERVATIVE FREE |
Applicant: | Abbvie |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Pharmacology for NDA: 020551
Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Suppliers and Packaging for NDA: 020551
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551 | NDA | AbbVie Inc. | 0074-4378 | 0074-4378-05 | 5 mL in 1 VIAL, SINGLE-DOSE (0074-4378-05) |
NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551 | NDA | AbbVie Inc. | 0074-4380 | 0074-4380-10 | 10 mL in 1 VIAL, MULTI-DOSE (0074-4380-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | AP | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 020551
Complete Access Available with Subscription